1. Home
  2. Downgrades
  3. Analyst Downgrades Dental Player Envista As Outlook Hinges on Improved Commercial Execution, Strategic Initiative Effectiveness

Analyst Downgrades Dental Player Envista As Outlook Hinges on Improved Commercial Execution, Strategic Initiative Effectiveness

2
0

Wednesday, Envista Holdings Corporation (NYSE:NVST) reported third-quarter 2024 sales of $645.6 million, beating the consensus of $643.44 million. Core sales declined 2% Y/Y in the quarter.

Net loss in the fourth quarter was $217.4 million or $1.27 per diluted share. The net loss included a $258.3 million non-cash charge related to the impairment of goodwill and intangible assets. 

Adjusted net income was $49.7 million or $0.29 per diluted share compared to adjusted net income of $91.9 million or $0.52 a year ago.

Adjusted EBITDA for the fourth quarter of 2023 was $100.5 million compared to $138.3 million in the fourth quarter of 2022. 

Amir Aghdaei, Chief Executive Officer, stated, “Despite a volatile macro backdrop in 2023, the Envista team delivered full year results in line with our expectations. For the …

Full story available on Benzinga.com

Visited 2 times, 1 visit(s) today